Eargo, Inc. (EAR) |
|
11.735 -0.235 (-1.96%)
|
02-03 15:51 |
|
Open: |
11.82 |
Pre. Close: |
11.97 |
|
High:
|
12.4499 |
Low:
|
11.68 |
|
Volume:
|
43,664 |
Market Cap:
|
243(M) |
|
|
|
Technical analysis |
as of: 2023-02-03 3:16:46 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 16.58 One year: 19.62 |
| Support: |
Support1: 10 Support2: 8.31 |
| Resistance: |
Resistance1: 14.2 Resistance2: 16.79 |
| Pivot: |
11.4  |
| Moving Average: |
MA(5): 11.34 MA(20): 11.56 
MA(100): 14.61 MA(250): 36.23 |
| MACD: |
MACD(12,26): -0.2 Signal(9): -0.3 |
| Stochastic oscillator: |
%K(14,3): 26 %D(3): 20.8 |
| RSI: |
RSI(14): 50.9 |
| 52-week: |
High: 116.8 Low: 0.8 |
| Average Vol(K): |
3-Month: 98 (K) 10-Days: 119 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ EAR ] has closed below upper band by 41.0%. Bollinger Bands are 44.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 73 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
12.47 - 12.52 |
12.52 - 12.57 |
|
Low:
|
11.68 - 11.73 |
11.73 - 11.78 |
|
Close:
|
11.89 - 11.97 |
11.97 - 12.07 |
|
Company Description |
|
Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. The company markets and sells hearing aids. It sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was incorporated in 2010 and is headquartered in San Jose, California. |
Headline News |
Fri, 03 Feb 2023
Healthy Tahoe: A guide to pediatric ear infections - Tahoe Daily Tribune
Fri, 03 Feb 2023
Eardrum perforation during attempt to dislodge bead from girl's ear leads to €250000 settlement - The Irish Times
Fri, 03 Feb 2023
Girl settles hearing loss case over ear procedure - RTE.ie
Fri, 03 Feb 2023
Influence of pneumatization on morphology of temporal bone-related vasculatures and their morphometric relationship ... - Nature.com
Fri, 03 Feb 2023
Girl who suffered perforated eardrum after attempt to remove bead settles for €250k - Irish Examiner
Thu, 02 Feb 2023
Mayo Clinic Q and A: Understanding ear infections - Times-West Virginian
|
Financial Analysis |
| Price to Book Value: |
Underperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Outperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Underperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
21 (M) |
| Shares Float |
0 (M) |
|
% Held by Insiders
|
82.5 (%) |
|
% Held by Institutions
|
3.4 (%) |
|
Shares Short
|
223 (K) |
|
Shares Short P.Month
|
265 (K) |
Stock Financials |
|
EPS
|
-4.47 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
-18.44 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
-387.1 |
|
Return on Assets (ttm)
|
-52.5 |
|
Return on Equity (ttm)
|
-480.7 |
|
Qtrly Rev. Growth
|
0 |
|
Gross Profit (p.s.)
|
0.2 |
|
Sales Per Share
|
1.65 |
|
EBITDA (p.s.)
|
-6.34 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-142 (M) |
|
Levered Free Cash Flow
|
-99 (M) |
Stock Valuations |
|
PE Ratio
|
-2.64 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
-0.64 |
|
Price to Sales
|
7.08 |
|
Price to Cash Flow
|
-1.72 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
